Structures by: Devaraj A.
Total: 17
C25H21BrN2O8
C25H21BrN2O8
Organic & biomolecular chemistry (2019) 17, 16 3884-3893
a=8.5538(5)Å b=28.5184(14)Å c=9.9217(5)Å
α=90.00° β=104.085(5)° γ=90.00°
C22H17BrN2O6
C22H17BrN2O6
Organic & biomolecular chemistry (2019) 17, 16 3884-3893
a=8.0079(7)Å b=10.6912(11)Å c=12.9965(11)Å
α=79.773(8)° β=82.666(7)° γ=69.817(8)°
C384H396N108O12Pt24
C384H396N108O12Pt24
Chemical communications (Cambridge, England) (2018) 54, 38 4814-4817
a=33.966(7)Å b=19.359(4)Å c=26.794(5)Å
α=90° β=90° γ=90°
Methyl (<i>E</i>)-2-[(2-nitrophenoxy)methyl]-3-phenylacrylate
C17H15NO5
Acta Crystallographica Section E (2012) 68, 6 o1748
a=24.0511(10)Å b=7.8521(3)Å c=19.7403(9)Å
α=90.00° β=121.661(3)° γ=90.00°
5,5'-Methylenebis(2-isopropoxybenzaldehyde)
C21H24O4
Acta Crystallographica Section E (2012) 68, 7 o2199
a=26.337(9)Å b=28.349(10)Å c=4.990(2)Å
α=90.00° β=90.00° γ=90.00°
2-[(6-Nitro-1,3-benzodioxol-5-yl)methylidene]malononitrile
C11H5N3O4
Acta Crystallographica Section E (2011) 67, 12 o3469
a=7.0953(2)Å b=8.8847(3)Å c=9.2212(3)Å
α=84.470(2)° β=67.634(2)° γ=78.874(2)°
(<i>E</i>)-Methyl 2-benzyl-3-<i>o</i>-tolylacrylate
C18H18O2
Acta Crystallographica Section E (2012) 68, 5 o1273
a=7.6277(3)Å b=16.2167(7)Å c=11.7990(5)Å
α=90.00° β=92.419(2)° γ=90.00°
(<i>E</i>)-3-(1,3-Benzodioxol-5-yl)-2-{[<i>N</i>-(2-formylphenyl)- 4-methylbenzenesulfonamido]methyl}prop-2-enenitrile
C25H20N2O5S
Acta Crystallographica Section E (2012) 68, 11 o3164-o3165
a=8.921(5)Å b=10.235(4)Å c=25.256(3)Å
α=90.00° β=93.380(4)° γ=90.00°
Methyl (<i>E</i>)-2-cyano-3-(6-nitro-1,3-benzodioxol-5-yl)acrylate
C12H8N2O6
Acta Crystallographica Section E (2012) 68, 11 o3184
a=10.8191(9)Å b=7.3220(6)Å c=15.4133(13)Å
α=90.00° β=91.691(2)° γ=90.00°
Methyl (2<i>Z</i>)-2-bromomethyl-3-(2,4-dichlorophenyl)prop-2-enoate
C11H9BrCl2O2
Acta Crystallographica Section E (2013) 69, 4 o572
a=7.9174(3)Å b=8.8032(3)Å c=9.3585(3)Å
α=78.374(2)° β=86.599(2)° γ=73.528(2)°
Methyl 3'-(2,5-dimethylbenzyl)-1'-methyl-2-oxo-4'-phenylspiro[indoline-3,2'-pyrrolidine]-3'-carboxylate chloroform monosolvate
C29H30N2O3,CHCl3
Acta Crystallographica Section E (2014) 70, 3 o377-o378
a=12.9164(4)Å b=17.6167(5)Å c=12.4548(5)Å
α=90.00° β=98.135(2)° γ=90.00°
Methyl 3'-benzyl-4'-(2-chlorophenyl)-1'-methyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate
C27H25ClN2O3
Acta Crystallographica Section E (2013) 69, 8 o1214
a=13.0887(6)Å b=14.0869(7)Å c=13.3521(7)Å
α=90.00° β=113.524(2)° γ=90.00°
Methyl 3'-benzyl-4'-(2,4-dichlorophenyl)-1'-methyl-2-oxo-1-propylspiro[indoline-3,2'-pyrrolidine]-3'-carboxylate
C30H30Cl2N2O3
Acta Crystallographica Section E (2014) 70, 3 o272
a=7.5563(4)Å b=28.8497(16)Å c=12.4274(8)Å
α=90.00° β=90.433(3)° γ=90.00°
Methyl 4'-(3-bromophenyl)-3'-(2,5-dimethylbenzyl)-1'-methyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate
C29H29BrN2O3
Acta Crystallographica Section E (2014) 70, 3 o299-o300
a=12.0673(4)Å b=9.4109(3)Å c=22.5852(7)Å
α=90.00° β=103.660(2)° γ=90.00°
Methyl 3'-benzyl-4'-(2,4-dichlorophenyl)-1'-methyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate
C27H24Cl2N2O3
Acta Crystallographica Section E (2014) 70, 3 o335
a=12.7051(5)Å b=14.1724(6)Å c=14.0322(6)Å
α=90.00° β=109.424(2)° γ=90.00°
C210H154Br2Cu6F18N30O24
C210H154Br2Cu6F18N30O24
ACS Catalysis (2019) 9, 3 1907
a=15.8225(7)Å b=19.4848(9)Å c=21.1157(10)Å
α=70.092(3)° β=81.078(3)° γ=72.501(2)°
C144H200N48Pd8,12(F6P),4(C2H6OS),4(NO3),12(O)
C144H200N48Pd8,12(F6P),4(C2H6OS),4(NO3),12(O)
Journal of the American Chemical Society (2019)
a=33.412(5)Å b=33.412(5)Å c=14.630(3)Å
α=90° β=90° γ=90°